Search Result

Results for "

light chain

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adenosine Receptor (1) Adenylate Cyclase (1) Amino Acid Decarboxylase (1) Amino Acid Derivatives (1) Amyloid-β (7) ANGPTL (2) Antibiotic (1) Antifolate (1) Apolipoprotein (1) Apoptosis (4) ATP-binding cassette (ABC) transporters (1) Autophagy (2) Bacterial (4) Bcl-2 Family (1) Biochemical Assay Reagents (11) c-Fms (1) c-Met/HGFR (2) C-type Lectin-like Receptors (CTLRs) (2) Cadherin (3) Calmodulin (5) CaMK (2) Casein Kinase (1) CCR (3) CD19 (2) CD276/B7-H3 (1) CD28 (1) CD3 (3) CD47 (1) CGRP Receptor (1) Chloride Channel (1) Complement System (1) CRAC Channel (1) CXCR (10) Discoidin Domain Receptor (1) EGFR (3) Endogenous Metabolite (2) Endothelin Receptor (1) Ephrin Receptor (2) Fc Receptor (FcR) (2) Ferroptosis (1) FGFR (3) G Protein-coupled Receptor Kinase (GRK) (1) GLUT (1) Glycosidase (1) HBV (1) HCV (3) Histone Methyltransferase (1) IFNAR (1) IKK (1) Integrin (6) Interleukin Related (18) Kallikrein (1) LDLR (1) Mesothelin (1) Microtubule/Tubulin (1) MMP (1) Myosin (12) NAMPT (1) Neuropeptide Y Receptor (1) Notch (2) PACAP Receptor (1) PAI-1 (1) Parasite (1) PCSK9 (1) PD-1/PD-L1 (3) Phosphatase (1) Phosphodiesterase (PDE) (2) PKA (2) PKC (1) Potassium Channel (2) Reference Standards (1) ROCK (3) Scavenger Receptor Class B type I (SR-BI） (1) Ser/Thr Protease (7) Sirtuin (1) Smo (1) Sodium Channel (2) TGF-beta/Smad (3) TGF-β Receptor (3) TNF Receptor (11) Toll-like Receptor (TLR) (4) Transmembrane Glycoprotein (19) TREM receptor (1) Trk Receptor (2) TSH Receptor (1) Tyrosinase (1) VEGFR (8) Wnt (2) β-catenin (1)
By Research Areas:	Cancer (19) Cardiovascular Disease (4) Infection (2) Inflammation/Immunology (289) Metabolic Disease (2) Neurological Disease (9)

By Targets:

Adenosine Receptor (1)

Adenylate Cyclase (1)

Amino Acid Decarboxylase (1)

Amino Acid Derivatives (1)

Amyloid-β (7)

ANGPTL (2)

Antibiotic (1)

Antifolate (1)

Apolipoprotein (1)

Apoptosis (4)

ATP-binding cassette (ABC) transporters (1)

Autophagy (2)

Bacterial (4)

Bcl-2 Family (1)

Biochemical Assay Reagents (11)

c-Fms (1)

c-Met/HGFR (2)

C-type Lectin-like Receptors (CTLRs) (2)

Cadherin (3)

Calmodulin (5)

CaMK (2)

Casein Kinase (1)

CCR (3)

CD19 (2)

CD276/B7-H3 (1)

CD28 (1)

CD3 (3)

CD47 (1)

CGRP Receptor (1)

Chloride Channel (1)

Complement System (1)

CRAC Channel (1)

CXCR (10)

Discoidin Domain Receptor (1)

EGFR (3)

Endogenous Metabolite (2)

Endothelin Receptor (1)

Ephrin Receptor (2)

Fc Receptor (FcR) (2)

Ferroptosis (1)

FGFR (3)

G Protein-coupled Receptor Kinase (GRK) (1)

GLUT (1)

Glycosidase (1)

HBV (1)

HCV (3)

Histone Methyltransferase (1)

IFNAR (1)

IKK (1)

Integrin (6)

Interleukin Related (18)

Kallikrein (1)

LDLR (1)

Mesothelin (1)

Microtubule/Tubulin (1)

MMP (1)

Myosin (12)

NAMPT (1)

Neuropeptide Y Receptor (1)

Notch (2)

PACAP Receptor (1)

PAI-1 (1)

Parasite (1)

PCSK9 (1)

PD-1/PD-L1 (3)

Phosphatase (1)

Phosphodiesterase (PDE) (2)

PKA (2)

PKC (1)

Potassium Channel (2)

Reference Standards (1)

ROCK (3)

Scavenger Receptor Class B type I (SR-BI） (1)

Ser/Thr Protease (7)

Sirtuin (1)

Smo (1)

Sodium Channel (2)

TGF-beta/Smad (3)

TGF-β Receptor (3)

TNF Receptor (11)

Toll-like Receptor (TLR) (4)

Transmembrane Glycoprotein (19)

TREM receptor (1)

Trk Receptor (2)

TSH Receptor (1)

Tyrosinase (1)

VEGFR (8)

Wnt (2)

β-catenin (1)

By Research Areas:

Cancer (19)

Cardiovascular Disease (4)

Infection (2)

Inflammation/Immunology (289)

Metabolic Disease (2)

Neurological Disease (9)

213

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

MCE Kits

292

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Antibodies

Birtamimab NEOD001	Amyloid-β	Neurological Disease
Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis .

Rhodblock 6	ROCK	Cancer
Rhodblock 6 is a Rho kinase (ROCK) inhibitor that inhibits phospho-MRLC (myosin regulatory light chain) localization .

Etentamig ABBV-383; TNB 383B	CD3	Cardiovascular Disease Inflammation/Immunology Cancer
Etentamig is a BCMA × CD3 bispecific T-cell engager (BiTE) that can inhibit the activity of B-cell maturation antigen (BCMA) and activate the T-cell surface glycoprotein CD3 complex. Etentamig can be used for research in multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases .

ROCK2-IN-8	ROCK	Neurological Disease
ROCK2-IN-8 (Compound 1) is an orally active ROCK2 inhibitor, with an IC₅₀ of 7.2 nM. ROCK2-IN-8 can be used for the research of aqueous humor outflow in porcine eyes and myosin light chain phosphorylation .

W-7 hydrochloride 5 Publications Verification	Phosphodiesterase (PDE) Myosin Apoptosis Calmodulin Potassium Channel	Cancer
W-7 hydrochloride is a selective calmodulin antagonist. W-7 hydrochloride inhibits the Ca ²⁺-calmodulin-dependent phosphodiesterase and *myosin light* chain kinase with IC₅₀ values of 28 μM and 51 μM, respectively. W-7 hydrochloride induces apoptosis and has antitumor and vascular relaxing activity. W-7 hydrochloride is a blocker of Kv4.3** and can be used for research of arrhythmias .

*Myosin Light* Chain Kinase Substrate (smooth muscle)**	Myosin	Cancer
Myosin Light Chain Kinase Substrate (smooth muscle) is a smooth muscle myosin light chain kinase (MLCK) synthetic peptide substrate .

smMLCK peptide Smooth-Muscle Myosin light-chain Kinase (796-815)	Myosin	Cardiovascular Disease Inflammation/Immunology
smMLCK peptide is a specific inhibitor of smooth muscle myosin light chain kinase (smMLCK). The smMLCK peptide mimics the substrate and competitively inhibits the binding of the actual substrate to the enzyme, thereby inhibiting the kinase activity. This inhibition prevents the phosphorylation of the myosin light chain, thus inhibiting muscle contraction .

LC kinetic stabilizer-2	Amyloid-β	Inflammation/Immunology
LC kinetic stabilizer-2 is a potent amyloidogenic immunoglobulin light chain (LC) kinetic stabilizer with an EC₅₀ of 24 nM .

LC kinetic stabilizer-1	Biochemical Assay Reagents	Others
LC kinetic stabilizer-1 (compound 21) is a potent and selective amyloidogenic immunoglobulin light chain kinetic stabilizer with EC₅₀s of 140 and 74.1 nM for WIL-FL ^* and WIL-FL ^* T46L/F49Y, respectively. WIL-FL is an amyloidogenic FL LC dimer .

β Amyloid (1-14), human	Amyloid-β	Neurological Disease
β Amyloid (1-14), human is a peptide fragment of β-amyloid protein (Aβ), which is obtained by hydrolysis of Aβ1-40 peptide by catalytic antibody light chain #7TR. β Amyloid (1-14), human can be used for Alzheimer's disease research .

Kemptamide	Myosin	Cancer
Kemptamide, a 13 amino acid fragment with a sequence corresponding to residues 11-23 of gizzard light chain. Kemptamide is a peptide substrate of myosin light-chain kinase (MLCK) .

Ragistomig	TNF Receptor PD-1/PD-L1	Inflammation/Immunology
Ragistomig is an anti-TNFRSF9/CD274 IgG1 monoclonal antibody composed of a κ light chain and a variable region with a λ light chain and an IgG1 heavy chain. The overall structure is a dimer composed of two identical IgG1 heavy chains .

Cemavafusp	PD-1/PD-L1	Inflammation/Immunology
Cemavafusp is an anti-PD-L1 monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain .

Lunaxafusp	EGFR	Inflammation/Immunology
Lunaxafusp is an anti-ERBB2 scFv-heavy-κ monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain .

Anti-amyloid agent-2	Amyloid-β	Cancer
Anti-amyloid agent-2 (compound (R)-38) is an amyloidogenic immunoglobulin light chain stabilizer .

BoNT-IN-1	Bacterial Antibiotic	Neurological Disease
BoNT-IN-1 is an effective inhibitor of botulinum toxin type A light chain (BoNTA LC), with an IC50 value of 0.9 μM.

MS-444 2 Publications Verification BE-34776	Myosin	Cancer
MS-444 inhibits the activity of purified smooth muscle myosin light chain kinase (MLCK) with an IC₅₀ value of 10 μM.

BoNT-IN-2	Bacterial	Others
BoNT-IN-2 (Compound 33) is a Botulinum Neurotoxin A Light Chain (BoNT/A LC) inhibitor with an IC₅₀ of 4.5 μM .

Myokinasib-II	Myosin	Cancer
Myokinasib-II is a myosin light chain kinase (MLCK) inhibitor, which is a potential target for inflammatory diseases, cancer and other diseases. .

Human immunoglobulin E Human IgE	Biochemical Assay Reagents	Inflammation/Immunology
Human immunoglobulin E (Human IgE) is a key mediator in allergic diseases. Human immunoglobulin E is made up of heavy (H) and light (L) chains, of which the variable (V) domains of the H chains are believed to contribute much to their antigenbinding properties .

MLCK Peptide	Calmodulin	Metabolic Disease
MLCK Peptide is a fully reversible, high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase .

TachypleginA-2	Parasite	Infection
TachypleginA-2 is a small-molecule inhibitor of parasite motility and invasion. TachypleginA-2 reproducibly induces the TgMLC1 (an essential light chain) mobility shift .

MLCK inhibitor peptide 18 5 Publications Verification	Myosin CaMK Autophagy	Others
MLCK inhibitor peptide 18 is a myosin light chain kinase (MLCK) inhibitor with an IC₅₀ of 50 nM, and inhibits CaM kinase II only at 4000-fold higher concentrations.

DCBY02	Transmembrane Glycoprotein	Inflammation/Immunology
DCBY02 is a monoclonal antibody targeting CD93 expressed in CHO cells. DCBY02 has a heavy chain of the mlgG type and a light chain of the mkappa type, with a predicted molecular weight (MW) of 150 kDa. The isotype control for DCBY02 can be referenced as Mouse IgG1 kappa, Isotype Control.

Anti-CLEC4C Antibody	C-type Lectin-like Receptors (CTLRs)	Inflammation/Immunology
Anti-CLEC4C Antibody is a CHO-expressed humanized antibody that targets CLEC4C. The Anti-CLEC4C Antibody carries a huIgG1 type heavy chain and a huλ type light chain, with a predicted molecular weight (MW) of 150 kDa.

Coltuximab	CD19	Inflammation/Immunology
Coltuximab is a CHO-expressed humanized antibody that targets CD19. Coltuximab is composed of huIgG1 heavy chains and huκ light chains, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Coltuximab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Vandortuzumab	Transmembrane Glycoprotein	Inflammation/Immunology
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 148.74 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Mibavademab	Neuropeptide Y Receptor	Inflammation/Immunology
Mibavademab is a CHO-expressed humanized antibody that targets LEPR/CD295. Mibavademab is equipped with a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.58 kDa. The isotype control for Mibavademab can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).

PY314	TREM receptor	Inflammation/Immunology
PY314 is a humanized antibody expressed in CHO, targeting TREM2. PY314 has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for PY314 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

FR104	CD28	Inflammation/Immunology
FR104 is a humanized antibody expressed in CHO cells that targets CD28. FR104 comprises a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for FR104 can be referenced as Human IgG2 kappa, Isotype Control (HY-P99002).

Anselamimab CAEL-101	Apolipoprotein Amyloid-β	Neurological Disease
Anselamimab (CAEL-101) is a chimeric monoclonal antibody for *systemic light* chain (AL) amyloidosis**. Anselamimab can promote phagocytic destruction and subsequent clearance of amyloid deposits. Anselamimab can be used in the research of amyloidosis .

Anti-Matriptase Antibody	Ser/Thr Protease	Inflammation/Immunology
Anti-Matriptase Antibody is a human-derived antibody expressed in CHO, targeting Matriptase. The Anti-Matriptase Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-Matriptase Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Anti-oxLDL Antibody	LDLR	Inflammation/Immunology
The Anti-oxLDL Antibody is a humanized antibody expressed in CHO cells that targets oxLDL. The Anti-oxLDL Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-oxLDL Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Torudokimab	Interleukin Related	Inflammation/Immunology
Torudokimab is a humanized antibody expressed in CHO, targeting IL-33. Torudokimab has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Torudokimab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).

Sapelizumab	Interleukin Related	Inflammation/Immunology
Sapelizumab is a CHO-expressed humanized antibody targeting IL-6Ra/CD126. Sapelizumab has a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Sapelizumab can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

Anti-Mesothelin Antibody	Mesothelin	Inflammation/Immunology
Anti-Mesothelin Antibody is a humanized antibody expressed in CHO that targets Mesothelin. The Anti-Mesothelin Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control of the Anti-Mesothelin Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Anti-HGFA Antibody	Ser/Thr Protease	Inflammation/Immunology
Anti-HGFA Antibody is a humanized antibody expressed in CHO cells, targeting HGFA. The Anti-HGFA Antibody contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-HGFA Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Senlizumab BAY-103356; CDP-571	TNF Receptor	Inflammation/Immunology
Senlizumab is a humanized antibody expressed in CHO cells that targets TNFSF2/TNFa. Senlizumab is composed of huIgG4SP heavy chains and huκ light chains, with a predicted molecular weight (MW) of 146.9 kDa. The isotype control for Senlizumab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).

Oportuzumab	Transmembrane Glycoprotein	Inflammation/Immunology
Oportuzumab is a CHO-expressed humanized antibody that targets EpCAM/TROP1/CD326. Oportuzumab contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Oportuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Anti-Hepsin Antibody	Ser/Thr Protease	Inflammation/Immunology
Anti-Hepsin Antibody is a CHO-expressed human antibody that targets Hepcidin. Anti-Hepsin Antibody has huIgG1 heavy chain and huλ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-Hepcidin/HAMP Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

PPO-allene	Bacterial	Neurological Disease
PPO-allene is a covalent botulinum neurotoxin (BoNT) light chain inhibitor (IC₅₀: 20.9 μM). PPO-allene (0.3 mg/kg, i.v.) demonstrates an in vivo half-life of approximately 1.5 h in mice .

VGX-100	VEGFR	Inflammation/Immunology
VGX-100 is a humanized antibody expressed in CHO cells, targeting VEGFC. VGX-100 is composed of huIgG1 heavy chains and huλ light chains, with a predicted molecular weight (MW) of 143.6 kDa. The isotype control for VGX-100 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

MB-311	Transmembrane Glycoprotein	Inflammation/Immunology
MB-311 is a humanized antibody expressed in CHO cells, targeting Lewis Y. MB-311 has a huIgG1 heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for MB-311 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Anti-TPBG Antibody	Wnt	Inflammation/Immunology
Anti-TPBG Antibody is a humanized antibody expressed in CHO cells, targeting TPBG. The Anti-TPBG Antibody is composed of a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.8 kDa. The isotype control for Anti-TPBG Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Alacizumab	VEGFR	Inflammation/Immunology
Alacizumab is a CHO-expressed humanized antibody that targets VEGFR2/KDR/CD309. Alacizumab contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.08 kDa. The isotype control for Alacizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Anti-LAP Antibody	TGF-beta/Smad	Inflammation/Immunology
Anti-LAP Antibody is a humanized antibody expressed in CHO cells, targeting LAP. The Anti-LAP Antibody features a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control of the Anti-LAP Antibody, you can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

Cat. No.	Product Name	Type

HY-W099538

Dilauryl thiodipropionate

Dilauryl 3,3'-Thiodipropionate

Biochemical Assay Reagents

Dilauryl thiodipropionate (DLTDP), which is a sulfur-containing antioxidant commonly used to stabilize polymers and plastics against degradation caused by heat, oxygen, and UV light, acts to scavenge free radicals and others that may cause polymer chain scission and cross-linked active substances, in addition, DLTDP has been used as an additive to lubricants, oils and other industrial fluids to improve their oxidation stability, the long hydrocarbon chain in DLTDP makes it low volatility and compatible with many materials and Good compatibility with substrates.

HY-NP201

Human immunoglobulin E Human IgE	Native Proteins
Human immunoglobulin E (Human IgE) is a key mediator in allergic diseases. Human immunoglobulin E is made up of heavy (H) and light (L) chains, of which the variable (V) domains of the H chains are believed to contribute much to their antigenbinding properties .

HY-W1048555B

Mal-PEG-SCM (MW 3400)

Drug Delivery

Mal-PEG-SCM (MW 3400) is a linear hetero-bifunctional PEG product with maleimide and succinimidyl NHS ester groups. Mal-PEG-SCM (MW 3400) is an important cross-linker with PEG chains. Maleimide reacts with thiols, SH, sulfhydryls or sulfhydryls, and SCM stands for succinimidyl carboxymethyl ester, which reacts with primary amines. Maleimide contains a reactive C=C double bond and is sensitive to light or oxygen .

HY-W1048555A

Mal-PEG-SCM (MW 2000)

Drug Delivery

Mal-PEG-SCM (MW 2000) is a linear hetero-bifunctional PEG product with maleimide and succinimidyl NHS ester groups. Mal-PEG-SCM (MW 2000) is an important cross-linker with PEG chains. Maleimide reacts with thiols, SH, sulfhydryls or sulfhydryls, and SCM stands for succinimidyl carboxymethyl ester, which reacts with primary amines. Maleimide contains a reactive C=C double bond and is sensitive to light or oxygen .

HY-W1048555D

Mal-PEG-SCM (MW 10000)

Drug Delivery

Mal-PEG-SCM (MW 10000) is a linear hetero-bifunctional PEG product with maleimide and succinimidyl NHS ester groups. Mal-PEG-SCM (MW 10000) is an important cross-linker with PEG chains. Maleimide reacts with thiols, SH, sulfhydryls or sulfhydryls, and SCM stands for succinimidyl carboxymethyl ester, which reacts with primary amines. Maleimide contains a reactive C=C double bond and is sensitive to light or oxygen .

HY-W1048555H

Mal-PEG-SCM (MW 40000)

Drug Delivery

Mal-PEG-SCM (MW 40000) is a linear hetero-bifunctional PEG product with maleimide and succinimidyl NHS ester groups. Mal-PEG-SCM (MW 40000) is an important cross-linker with PEG chains. Maleimide reacts with thiols, SH, sulfhydryls or sulfhydryls, and SCM stands for succinimidyl carboxymethyl ester, which reacts with primary amines. Maleimide contains a reactive C=C double bond and is sensitive to light or oxygen .

HY-W1048555C

Mal-PEG-SCM (MW 5000)

Drug Delivery

Mal-PEG-SCM (MW 5000) is a linear hetero-bifunctional PEG product with maleimide and succinimidyl NHS ester groups. Mal-PEG-SCM (MW 5000) is an important cross-linker with PEG chains. Maleimide reacts with thiols, SH, sulfhydryls or sulfhydryls, and SCM stands for succinimidyl carboxymethyl ester, which reacts with primary amines. Maleimide contains a reactive C=C double bond and is sensitive to light or oxygen .

HY-W1048555E

Mal-PEG-SCM (MW 20000)

Drug Delivery

Mal-PEG-SCM (MW 20000) is a linear hetero-bifunctional PEG product with maleimide and succinimidyl NHS ester groups. Mal-PEG-SCM (MW 20000) is an important cross-linker with PEG chains. Maleimide reacts with thiols, SH, sulfhydryls or sulfhydryls, and SCM stands for succinimidyl carboxymethyl ester, which reacts with primary amines. Maleimide contains a reactive C=C double bond and is sensitive to light or oxygen .

HY-W1048555

Mal-PEG-SCM (MW 1000)

Drug Delivery

Mal-PEG-SCM (MW 1000) is a linear hetero-bifunctional PEG product with maleimide and succinimidyl NHS ester groups. Mal-PEG-SCM (MW 1000) is an important cross-linker with PEG chains. Maleimide reacts with thiols, SH, sulfhydryls or sulfhydryls, and SCM stands for succinimidyl carboxymethyl ester, which reacts with primary amines. Maleimide contains a reactive C=C double bond and is sensitive to light or oxygen .

HY-W099538R

Dilauryl thiodipropionate (Standard)

Dilauryl 3,3'-Thiodipropionate (Standard)

Biochemical Assay Reagents

Dilauryl thiodipropionate (Standard) is the analytical standard of Dilauryl thiodipropionate. This product is intended for research and analytical applications. Dilauryl thiodipropionate (DLTDP), which is a sulfur-containing antioxidant commonly used to stabilize polymers and plastics against degradation caused by heat, oxygen, and UV light, acts to scavenge free radicals and others that may cause polymer chain scission and cross-linked active substances, in addition, DLTDP has been used as an additive to lubricants, oils and other industrial fluids to improve their oxidation stability, the long hydrocarbon chain in DLTDP makes it low volatility and compatible with many materials and Good compatibility with substrates.

Cat. No.	Product Name	Target	Research Area

HY-P1029

MLCK inhibitor peptide 18 5 Publications Verification	Myosin CaMK Autophagy	Others
MLCK inhibitor peptide 18 is a myosin light chain kinase (MLCK) inhibitor with an IC₅₀ of 50 nM, and inhibits CaM kinase II only at 4000-fold higher concentrations.

HY-P5998

*Myosin Light* Chain Kinase Substrate (smooth muscle)**	Myosin	Cancer
Myosin Light Chain Kinase Substrate (smooth muscle) is a smooth muscle myosin light chain kinase (MLCK) synthetic peptide substrate .

HY-P10346

smMLCK peptide Smooth-Muscle Myosin light-chain Kinase (796-815)	Myosin	Cardiovascular Disease Inflammation/Immunology
smMLCK peptide is a specific inhibitor of smooth muscle myosin light chain kinase (smMLCK). The smMLCK peptide mimics the substrate and competitively inhibits the binding of the actual substrate to the enzyme, thereby inhibiting the kinase activity. This inhibition prevents the phosphorylation of the myosin light chain, thus inhibiting muscle contraction .

HY-P3214

*Myosin light* chain kinase fragment 11-19 amide** MLCK(11-19) amide	Peptides	Cancer
Myosin light chain kinase fragment 11-19 amide (MLCK(11-19) amide) is a substrate-specific peptide inhibitor of MLCK. Myosin light chain kinase fragment 11-19 amide inhibits hypotonicity-induced Ca ²⁺ entry. Myosin light chain kinase fragment 11-19 amide can be used in the research of human cervical cancer .

HY-P10628

β Amyloid (1-14), human	Amyloid-β	Neurological Disease
β Amyloid (1-14), human is a peptide fragment of β-amyloid protein (Aβ), which is obtained by hydrolysis of Aβ1-40 peptide by catalytic antibody light chain #7TR. β Amyloid (1-14), human can be used for Alzheimer's disease research .

HY-P2162

Kemptamide	Myosin	Cancer
Kemptamide, a 13 amino acid fragment with a sequence corresponding to residues 11-23 of gizzard light chain. Kemptamide is a peptide substrate of myosin light-chain kinase (MLCK) .

HY-P10165

MLCK Peptide	Calmodulin	Metabolic Disease
MLCK Peptide is a fully reversible, high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase .

HY-P10166

MLCK Peptide, control	Peptides	Others
MLCK Peptide, control is a myosin light-chain kinase. Adding MLCK peptide to permeabilized L15 cells dramatically decreased IICR. MLCK peptide caused a reduction in the extent of IICR with no change in the affinity of IP3 for the IP3R .

HY-P1805

Calmodulin Binding Peptide 1	Calmodulin	Neurological Disease
Calmodulin Binding Peptide 1 is a high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase (MLCK peptide), which strongly inhibits IP3-induced Ca ²⁺ release .

Cat. No.	Product Name

HY-K0215

Protein L Agarose
MCE Protein L Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein L, effectively purifies mammalian monoclonal and polyclonal antibodies which have kappa light chain.

Cat. No.	Product Name	Target	Research Area

HY-P990120

*Anti-Rat Kappa Immunoglobulin Light* Chain Antibody (MAR 18.5)**	Inhibitory Antibodies	Inflammation/Immunology
Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) is an anti-rat Kappa Immunoglobulin Light Chain IgG2a monoclonal antibody. Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) can enhance B cell depletion. Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) can enhance T cell exhaustion after the injection of CD4 mAb (HY-P990792) and CD8 mAb (HY-P99129). Anti-Rat Kappa Immunoglobulin Light Chain Antibody (MAR 18.5) can be used for research on immunology .

HY-P99481

Birtamimab NEOD001	Amyloid-β	Neurological Disease
Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis .

HY-P990785

Etentamig ABBV-383; TNB 383B	CD3	Cardiovascular Disease Inflammation/Immunology Cancer
Etentamig is a BCMA × CD3 bispecific T-cell engager (BiTE) that can inhibit the activity of B-cell maturation antigen (BCMA) and activate the T-cell surface glycoprotein CD3 complex. Etentamig can be used for research in multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases .

HY-P990572

DCBY02	Transmembrane Glycoprotein	Inflammation/Immunology
DCBY02 is a monoclonal antibody targeting CD93 expressed in CHO cells. DCBY02 has a heavy chain of the mlgG type and a light chain of the mkappa type, with a predicted molecular weight (MW) of 150 kDa. The isotype control for DCBY02 can be referenced as Mouse IgG1 kappa, Isotype Control.

HY-P990119

*Anti-Mouse Kappa Immunoglobulin Light* Chain Antibody (HB-58)**	Inhibitory Antibodies	Inflammation/Immunology
Anti-Mouse Kappa Immunoglobulin Light Chain Antibody (HB-58) is an anti-mouse Kappa Immunoglobulin Light Chain IgG1 monoclonal antibody. Anti-Mouse Kappa Immunoglobulin Light Chain Antibody (HB-58) can reduce the phosphorylation levels of Src and Syk in B cells and the antigen presentation ability of B cells. Anti-Mouse Kappa Immunoglobulin Light Chain Antibody (HB-58) can be used for research on immunology .

HY-P990757

Ragistomig	TNF Receptor PD-1/PD-L1	Inflammation/Immunology
Ragistomig is an anti-TNFRSF9/CD274 IgG1 monoclonal antibody composed of a κ light chain and a variable region with a λ light chain and an IgG1 heavy chain. The overall structure is a dimer composed of two identical IgG1 heavy chains .

HY-P990718

Cemavafusp	PD-1/PD-L1	Inflammation/Immunology
Cemavafusp is an anti-PD-L1 monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain .

HY-P990695

Lunaxafusp	EGFR	Inflammation/Immunology
Lunaxafusp is an anti-ERBB2 scFv-heavy-κ monoclonal antibody composed of a single chain variable fragment, an antibody heavy chain, and a kappa antibody light chain .

HY-P990355

Anti-CD5 Antibody	Inhibitory Antibodies	Inflammation/Immunology
The Anti-CD5 Antibody is a human-derived antibody expressed in CHO, targeting CD5. The Anti-CD5 Antibody contains huIgG2 heavy chains and huκ light chains, with a predicted molecular weight (MW) of 150 kDa.

HY-P990373

Anti-CLEC4C Antibody	C-type Lectin-like Receptors (CTLRs)	Inflammation/Immunology
Anti-CLEC4C Antibody is a CHO-expressed humanized antibody that targets CLEC4C. The Anti-CLEC4C Antibody carries a huIgG1 type heavy chain and a huλ type light chain, with a predicted molecular weight (MW) of 150 kDa.

HY-P990654

Radretumab	Inhibitory Antibodies	Inflammation/Immunology
Radretumab is a CHO-expressed humanized antibody that targets Fibronectin. Radretumab has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 144.2 kDa. The isotype control for Radretumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990571

Coltuximab	CD19	Inflammation/Immunology
Coltuximab is a CHO-expressed humanized antibody that targets CD19. Coltuximab is composed of huIgG1 heavy chains and huκ light chains, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Coltuximab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990673

Vandortuzumab	Transmembrane Glycoprotein	Inflammation/Immunology
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 148.74 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990631

Mibavademab	Neuropeptide Y Receptor	Inflammation/Immunology
Mibavademab is a CHO-expressed humanized antibody that targets LEPR/CD295. Mibavademab is equipped with a huIgG4SP heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.58 kDa. The isotype control for Mibavademab can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P990651

PY314	TREM receptor	Inflammation/Immunology
PY314 is a humanized antibody expressed in CHO, targeting TREM2. PY314 has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for PY314 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990587

FR104	CD28	Inflammation/Immunology
FR104 is a humanized antibody expressed in CHO cells that targets CD28. FR104 comprises a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for FR104 can be referenced as Human IgG2 kappa, Isotype Control (HY-P99002).

HY-P99105

Anselamimab CAEL-101	Apolipoprotein Amyloid-β	Neurological Disease
Anselamimab (CAEL-101) is a chimeric monoclonal antibody for *systemic light* chain (AL) amyloidosis**. Anselamimab can promote phagocytic destruction and subsequent clearance of amyloid deposits. Anselamimab can be used in the research of amyloidosis .

HY-P990616

LY2525623	Inhibitory Antibodies	Inflammation/Immunology
LY2525623 is a humanized antibody expressed in CHO targeting IL-23. LY2525623 has a huIgG1 type heavy chain and huκ type light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for LY2525623 can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990464

Anti-Matriptase Antibody	Ser/Thr Protease	Inflammation/Immunology
Anti-Matriptase Antibody is a human-derived antibody expressed in CHO, targeting Matriptase. The Anti-Matriptase Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-Matriptase Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990568

CLN-619	Inhibitory Antibodies	Inflammation/Immunology
CLN-619 is a human antibody expressed in CHO that targets MICA. CLN-619 carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 146.06 kDa. The isotype control for CLN-619 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990546

Apamistamab	Inhibitory Antibodies	Inflammation/Immunology
Apamistamab is a CHO-expressed human antibody that targets PTPRC/CD45. Apamistamab carries a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 146.52 kDa. The isotype control for Apamistamab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990480

Anti-oxLDL Antibody	LDLR	Inflammation/Immunology
The Anti-oxLDL Antibody is a humanized antibody expressed in CHO cells that targets oxLDL. The Anti-oxLDL Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for the Anti-oxLDL Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990473

Anti-MUSK Antibody	Inhibitory Antibodies	Inflammation/Immunology
Anti-MUSK Antibody is a humanized antibody expressed in CHO that targets MUSK. The Anti-MUSK Antibody contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145 kDa. For the isotype control of Anti-MUSK Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990629

MEDI-578	Inhibitory Antibodies	Inflammation/Immunology
MEDI-578 is a CHO-expressed human antibody that targets NGF/bNGF. MEDI-578 has a huIgG2a heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for MEDI-578 can be referenced as Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P990636

NGM-313 MK-3655	Inhibitory Antibodies	Inflammation/Immunology
NGM-313 is a CHO-expressed human antibody targeting Klotho Beta. NGM-313 contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for NGM-313 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990669

Torudokimab	Interleukin Related	Inflammation/Immunology
Torudokimab is a humanized antibody expressed in CHO, targeting IL-33. Torudokimab has a huIgG4SP type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.22 kDa. The isotype control for Torudokimab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P990545

Tanruprubart 1 Publications Verification ANX005	Inhibitory Antibodies	Inflammation/Immunology
ANX005 is a human-derived antibody expressed in CHO cells, targeting C1q. ANX005 contains huIgG1 heavy chains and huκ light chains, with a predicted molecular weight (MW) of 145 kDa. The isotype control for ANX005 can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990662

Sapelizumab	Interleukin Related	Inflammation/Immunology
Sapelizumab is a CHO-expressed humanized antibody targeting IL-6Ra/CD126. Sapelizumab has a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Sapelizumab can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

HY-P990427

Anti-Haptoglobin Antibody	Inhibitory Antibodies	Inflammation/Immunology
Anti-Haptoglobin Antibody is a humanized antibody expressed in CHO cells that targets Haptoglobin. The Anti-Haptoglobin Antibody is equipped with a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-Haptoglobin Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990410

Anti-ERG Antibody	Inhibitory Antibodies	Inflammation/Immunology
Anti-ERG Antibody is a humanized antibody expressed in CHO, targeting ERG. The Anti-ERG Antibody is composed of a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-ERG Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990388

Anti-CXADR Antibody	Inhibitory Antibodies	Inflammation/Immunology
Anti-CXADR Antibody is a humanized antibody expressed in CHO, targeting CXADR. The Anti-CXADR Antibody has a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-CXADR Antibody can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

HY-P990635

NGM-120	Inhibitory Antibodies	Inflammation/Immunology
NGM-120 is a CHO-expressed human antibody that targets GFRAL. NGM-120 contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145.7 kDa. The isotype control for NGM-120 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990466

Anti-Mesothelin Antibody	Mesothelin	Inflammation/Immunology
Anti-Mesothelin Antibody is a humanized antibody expressed in CHO that targets Mesothelin. The Anti-Mesothelin Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control of the Anti-Mesothelin Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990431

Anti-HGFA Antibody	Ser/Thr Protease	Inflammation/Immunology
Anti-HGFA Antibody is a humanized antibody expressed in CHO cells, targeting HGFA. The Anti-HGFA Antibody contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti-HGFA Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990322

AMG-811	Inhibitory Antibodies	Inflammation/Immunology
AMG-811 is a CHO expressed human antibody that targets IFNg. AMG-811 carries a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for AMG-811 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990564

Senlizumab BAY-103356; CDP-571	TNF Receptor	Inflammation/Immunology
Senlizumab is a humanized antibody expressed in CHO cells that targets TNFSF2/TNFa. Senlizumab is composed of huIgG4SP heavy chains and huκ light chains, with a predicted molecular weight (MW) of 146.9 kDa. The isotype control for Senlizumab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P990600

Icatolimab	Inhibitory Antibodies	Inflammation/Immunology
Icatolimab is a CHO-expressed humanized antibody targeting BTLA/CD272. Icatolimab contains huIgG4SP type heavy chains and huκ type light chains, with a predicted molecular weight (MW) of 146 kDa. The isotype control for Icatolimab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).

HY-P990642

Oportuzumab	Transmembrane Glycoprotein	Inflammation/Immunology
Oportuzumab is a CHO-expressed humanized antibody that targets EpCAM/TROP1/CD326. Oportuzumab contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Oportuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990549

ASK-8007	Inhibitory Antibodies	Inflammation/Immunology
ASK-8007 is a humanized antibody expressed by CHO, targeting Osteopontin. ASK-8007 has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.02 kDa. The isotype control for ASK-8007 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990610

KHK-2898	Inhibitory Antibodies	Inflammation/Immunology
KHK-2898 is a humanized antibody expressed in CHO targeting CD98. KHK-2898 has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for KHK-2898 can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990429

Anti-Hepsin Antibody	Ser/Thr Protease	Inflammation/Immunology
Anti-Hepsin Antibody is a CHO-expressed human antibody that targets Hepcidin. Anti-Hepsin Antibody has huIgG1 heavy chain and huλ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-Hepcidin/HAMP Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990675

VGX-100	VEGFR	Inflammation/Immunology
VGX-100 is a humanized antibody expressed in CHO cells, targeting VEGFC. VGX-100 is composed of huIgG1 heavy chains and huλ light chains, with a predicted molecular weight (MW) of 143.6 kDa. The isotype control for VGX-100 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990622

MB-311	Transmembrane Glycoprotein	Inflammation/Immunology
MB-311 is a humanized antibody expressed in CHO cells, targeting Lewis Y. MB-311 has a huIgG1 heavy chain and a huλ light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for MB-311 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990532

Anti-TPBG Antibody	Wnt	Inflammation/Immunology
Anti-TPBG Antibody is a humanized antibody expressed in CHO cells, targeting TPBG. The Anti-TPBG Antibody is composed of a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145.8 kDa. The isotype control for Anti-TPBG Antibody can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990318

Alacizumab	VEGFR	Inflammation/Immunology
Alacizumab is a CHO-expressed humanized antibody that targets VEGFR2/KDR/CD309. Alacizumab contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.08 kDa. The isotype control for Alacizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990460

Anti-LAP Antibody	TGF-beta/Smad	Inflammation/Immunology
Anti-LAP Antibody is a humanized antibody expressed in CHO cells, targeting LAP. The Anti-LAP Antibody features a huIgG2 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 150 kDa. For isotype control of the Anti-LAP Antibody, you can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

HY-P990658

RG-7652	Inhibitory Antibodies	Inflammation/Immunology
RG-7652 is a humanized antibody expressed in CHO cells, targeting PCSK9. RG-7652 contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145.88 kDa. The isotype control for RG-7652 can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990544

Anti-vWF Antibody AJW 200; AJvW 2	Integrin	Inflammation/Immunology
Anti-vWF Antibody is a humanized antibody expressed in CHO cells that targets vWF. The Anti-vWF Antibody is equipped with huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145.62 kDa. The isotype control for Anti-vWF Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990591

GSK-1070806 Aletekitug	Interleukin Related	Inflammation/Immunology
GSK-1070806 is a CHO-expressed humanized antibody that targets IL-18. GSK-1070806 contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 147.38 kDa. The isotype control for GSK-1070806 can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P990570

CMAB008	Inhibitory Antibodies	Inflammation/Immunology
CMAB008 is a humanized antibody expressed in CHO cells that targets TNFSF2/TNFa. CMAB008 contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for CMAB008 can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N6871

Abietic acid 1 Publications Verification	Infection Structural Classification Colophony Classification of Application Fields Pinaceae Ketones, Aldehydes, Acids Metabolic Disease Plants Inflammation/Immunology Disease Research Fields	Bacterial IKK Ferroptosis
Abietic acid, an orally active diterpene isolated from Colophony, displays significant anti-proliferative, anti-inflammatory, anti-obesity effect, bacteriostatic, cell cycle arresting and pro-apoptotic activities. Abietic acid inhibits lipoxygenase activity for allergy. Abietic acid enhances cell migration and tube formation in HUVECs. Abietic acid induces significant angiogenic potential, which is associated with upregulation of extracellular signal-regulated kinase (ERK) and p38 expression. Abietic acid attenuates sepsis-induced lung injury by inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway to inhibit M1 macrophage polarization. Abietic acid exhibits a positive effect against liver injury by attenuating inflammation and ferroptosis. Abietic acid shows accelerated wound closure in a mouse model of cutaneous wounds. Abietic acid significantly reduces the proliferation and growth of NSCLC cells by IKKβ inhibition.Additionally, Abietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice. Abietic acid is promising for research in non-small-cell lung cancer (NSCLC), liver injury-related deseases and psoriasis .

HY-N15301

Nocarnickelamide B	Structural Classification Microorganisms Ketones, Aldehydes, Acids Source classification	ROCK Myosin
Nocarnickelamide B (Compound 2) is a linear peptide and ROCK1/2 inhibitor. Nocarnickelamide B exhibits dual inhibitory activity against ROCK1 and ROCK2 with IC₅₀s of 14.9 μM and 21.9 μM, respectively. Nocarnickelamide B binds to the ATP-binding site. Nocarnickelamide B inhibits the activation of ROCK-regulated cytoskeletal contraction markers such as the myosin light chain. Nocarnickelamide B is potential for glaucoma reasearch .

Species:	Human (15) Rat (1) Pig (2)
Tag:	His (16) Tag Free (2) GST (1)
Source:	HEK293 (2) P. pastoris (2) Sf9 insect cells (2) E. coli (12)

Cat. No.	Compare	Product Name	Species	Source

HY-P70245

	*Ferritin light* chain/FTL Protein, Human (His)** rHuFerritin light chain/FTL, His; Ferritin L subunit; Ferritin light chain; FTL	Human	E. coli
	Ferritin light chain/FTL protein is pivotal in iron homeostasis, storing iron in a soluble, non-toxic form and delivering it to cells. In kidney development, FTL mediates iron uptake in capsule cells, crucial for organogenesis. Structurally, FTL, an oligomer with light and heavy subunits forming a spherical shell, facilitates iron entry through pores. Mutations in the C-terminus disrupt pore formation, impacting iron accumulation. Ferritin light chain/FTL Protein, Human (His) is the recombinant human-derived Ferritin light chain/FTL protein, expressed by E. coli , with N-6*His labeled tag.

HY-P70048

	PIN/DYNLL1 Protein, Human (His) rHuDynein light chain 1, cytoplasmic/DYNLL1, His; Dynein light chain 1 Cytoplasmic; 8 kDa Dynein light chain; DLC8; Dynein light chain LC8-Type 1; Protein Inhibitor of Neuronal Nitric Oxide Synthase; PIN; DYNLL1; DLC1; DNCL1; DNCLC1; HDLC1	Human	E. coli
	PIN/DYNLL1 acts as a non-catalytic accessory component in the cytoplasmic dynein 1 complex, connecting dynein to cargos and adapter proteins for dynein modulation. It functions as a motor for retrograde vesicle movement along microtubules, potentially influencing cytoskeletal structure. PIN/DYNLL1 enhances ESR1 transactivation and aids ESR1 nuclear localization. PIN/DYNLL1 Protein, Human (His) is the recombinant human-derived PIN/DYNLL1 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P70909

	MAP1LC3B Protein, Human Microtubule-associated proteins 1A/1B light chain 3B; Autophagy-related protein LC3 B; Autophagy-related ubiquitin-like modifier LC3 B; MAP1 light chain 3-like protein 2; MAP1A/MAP1B light chain 3 B; MAP1A/MAP1B LC3 B; Microtubule-associated protein 1 light cha	Human	E. coli
	MAP1LC3B is a key ubiquitin-like modifier essential for the formation of autophagosome vacuoles, which maintains cellular homeostasis. In mitophagy, it regulates mitochondrial number, suppresses reactive oxygen species and ensures energy efficiency. MAP1LC3B Protein, Human is the recombinant human-derived MAP1LC3B protein, expressed by E. coli , with tag free.

HY-P72189

	Coagulation Factor XII/F12 Protein, Pig (His) F12 Coagulation factor XII; EC 3.4.21.38; Hageman factor; HAF; Coagulation factor XIIa heavy chain; Coagulation factor XIIa light chain	Pig	E. coli
	Coagulation factor XII (F12) is a serum glycoprotein that plays multiple roles in initiating blood coagulation, fibrinolysis, and the production of bradykinin and angiotensin. It is involved in these complex processes, including cleavage of prekallikrein to form kallikrein, which subsequently cleaves factor XII initially to α-factor XIIa and then, after trypsin cleavage, to β-factor XIIa. Coagulation Factor XII/F12 Protein, Pig (His) is the recombinant pig-derived Coagulation Factor XII/F12 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P704106

	MYL9 Protein, Human (P. pastoris, His) Myosin regulatory light polypeptide 9; MYL9; MLC2; MRLC1; MYRL2; 20 kDa myosin light chain (LC20); MLC-2C; Myosin RLC; Myosin regulatory light chain 2, smooth muscle isoform; Myosin regulatory light chain 9; Myosin regulatory light chain MRLC1	Human	P. pastoris
	MYL9 Protein, Human (P. pastoris, His) is the recombinant human-derived MYL9 protein, expressed by P. pastoris, with C-10*His tag.

HY-P704107

	MYL12B Protein, Human (His) MRLC2; MYLC2B; MLC-2A (MLC-2); Myosin regulatory light chain 2-B, smooth muscle isoform; Myosin regulatory light chain 20 kDa (MLC20); Myosin regulatory light chain MRLC2; SHUJUN-1	Human	E. coli
	MYL12B Protein, Human (His) is the recombinant human-derived MYL12B protein, expressed by E. coli, with C-6*His tag.

HY-P71939

	Plasminogen Protein, Human Plasmin; Plasmin heavy chain A; Plasmin light chain B; Plasminogen; PLG; PLMN_HUMAN	Human	E. coli
	Plasminogen protein is the key precursor of plasmin and plays a central role in a variety of physiological and pathological processes. Plasmin is derived from plasminogen and dissolves fibrin during blood coagulation, affecting embryonic development, tissue remodeling, tumor invasion and inflammation. Plasminogen Protein, Human is the recombinant human-derived Plasminogen protein, expressed by E. coli , with tag free.

HY-P76469

	KLC2 Protein, Human (sf9, His-GST) Kinesin light chain 2; KLC 2	Human	Sf9 insect cells
	The KLC2 protein is a key kinesin-1 complex component that is essential for the generation of microtubule-associated forces and organelle transport. Its light chain facilitates the coupling of cargo to the heavy chain and regulates ATPase activity. KLC2 Protein, Human (sf9, His-GST) is the recombinant human-derived KLC2 protein, expressed by Sf9 insect cells , with C-His, N-GST labeled tag.

HY-P704105

	MYL12A Protein, Human (His) Myosin regulatory light chain 12A; MYL12A; MLCB; MRLC3; RLC; Epididymis secretory protein Li 24 (HEL-S-24); MLC-2B; Myosin RLC; Myosin regulatory light chain 2, nonsarcomeric; Myosin regulatory light chain MRLC3	Human	E. coli
	MYL12A Protein, Human (His) is the recombinant human-derived MYL12A protein, expressed by E. coli, with C-6*His tag.

HY-P70916

	MAP1LC3A Protein, Human (His) Microtubule-Associated Proteins 1A/1B light chain 3A; Autophagy-Related Protein LC3 A; Autophagy-Related Ubiquitin-Like Modifier LC3 A; MAP1 light chain 3-Like Protein 1; MAP1A/MAP1B light chain 3 A; MAP1A/MAP1B LC3 A; Microtubule-Associated Protein 1 light Cha	Human	E. coli
	MAP1LC3A is a key ubiquitin-like modifier essential for autophagosome vacuole formation, ensuring cellular homeostasis. As part of the GABARAP/GATE-16 subfamily, it plays a crucial role in late autophagosome maturation. MAP1LC3A Protein, Human (His) is the recombinant human-derived MAP1LC3A protein, expressed by E. coli , with C-6*His labeled tag.

HY-P700599

	Coagulation Factor XII/F12 Protein, Pig (P. pastoris, His) F12 Coagulation factor XII; EC 3.4.21.38; Hageman factor; HAF; Coagulation factor XIIa heavy chain; Coagulation factor XIIa light chain	Pig	P. pastoris
	Coagulation factor XII (F12) is a serum glycoprotein that plays multiple roles in initiating blood coagulation, fibrinolysis, and the production of bradykinin and angiotensin. It is involved in these complex processes, including cleavage of prekallikrein to form kallikrein, which subsequently cleaves factor XII initially to α-factor XIIa and then, after trypsin cleavage, to β-factor XIIa. Coagulation Factor XII/F12 Protein, Pig (P. pastoris, His) is the recombinant pig-derived F12/Coagulation Factor XII, Pig, expressed by P. pastoris , with N-6*His labeled tag.

HY-P73046

	Coagulation Factor XI/F11 Protein, Human (HEK293, His) Coagulation factor XI; Coagulation factor XIa light chain; PTA; FXI; F11	Human	HEK293
	Coagulation factor XI (F11) occupies a central position in the middle phase of the intrinsic pathway of blood coagulation, where it assumes the key role of activating factor IX. This complex process plays a key role in the chain of events that lead to the formation of a blood clot. Coagulation Factor XI/F11 Protein, Human (HEK293, His) is the recombinant human-derived Coagulation Factor XI/F11 protein, expressed by HEK293 , with C-His labeled tag.

HY-P70231

	Coagulation factor IX/F9 Protein, Human (HEK293, His) rHuCoagulation factor IX/F9, His; F9; Coagulation factor IX; Christmas factor; Plasma thromboplastin component; Coagulation factor IXa light chain; Coagulation factor IXa heavy chain	Human	HEK293
	Factor IX (F9) is a vitamin K-dependent plasma protein that plays a critical role in the intrinsic pathway of coagulation. Factor IX coordinates the conversion of factor X to its active form in the presence of Ca(2+) ions, phospholipids, and factor VIIIa. Coagulation factor IX/F9 Protein, Human (HEK293, His) is the recombinant human-derived Coagulation factor IX/F9 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P70531

	S100A8 Protein, Human (C-His) 1 Publications Verification Protein S100-A8; S100A8; Calgranulin-A; Cystic fibrosis antigen; Leukocyte L1 complex light chain; MRP-8	Human	E. coli
	S100A8 consists of calcium and zinc bound S100A8, which plays a critical regulatory role in inflammation and immune responses. As calprotectin, it contributes to leukocyte function, regulates the cytoskeleton, and activates intracellular NADPH oxidase. S100A8 Protein, Human (C-His) is the recombinant human-derived S100A8 protein, expressed by E. coli , with C-6*His labeled tag.

HY-P70531A

	S100A8 Protein, Human (N-His) Protein S100-A8; S100A8; Calgranulin-A; Cystic fibrosis antigen; Leukocyte L1 complex light chain; MRP-8	Human	E. coli
	S100A8 consists of calcium and zinc bound S100A8, which plays a critical regulatory role in inflammation and immune responses. As calprotectin, it contributes to leukocyte function, regulates the cytoskeleton, and activates intracellular NADPH oxidase. S100A8 Protein, Human (N-His) is the recombinant human-derived S100A8 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P76586

	S100A8 Protein, Human (sf9, His) Protein S100-A8; S100A8; Calgranulin-A; Cystic fibrosis antigen; Leukocyte L1 complex light chain; MRP-8	Human	Sf9 insect cells
	S100A8 consists of calcium and zinc bound S100A8, which plays a critical regulatory role in inflammation and immune responses. As calprotectin, it contributes to leukocyte function, regulates the cytoskeleton, and activates intracellular NADPH oxidase. S100A8 Protein, Human (sf9, His) is the recombinant human-derived S100A8 protein, expressed by Sf9 insect cells , with C-His labeled tag.

HY-P72188

	Coagulation Factor XI/F11 Protein, Human (His) coagulation factor XI; Coagulation factor XIa light chain; F11; FA11_HUMAN; FXI; MGC141891; Plasma thromboplastin antecedent; Platelet coagulation factor XI ; PTA	Human	E. coli
	Coagulation factor XI (F11) occupies a central position in the middle phase of the intrinsic pathway of blood coagulation, where it assumes the key role of activating factor IX. This complex process plays a key role in the chain of events that lead to the formation of a blood clot. Coagulation Factor XI/F11 Protein, Human (His) is the recombinant human-derived Coagulation Factor XI/F11 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P71275

	S100A8 Protein, Rat (His) 2 Publications Verification Protein S100-A8; S100a8; Calgranulin-A; Chemotactic cytokine CP-10; Leukocyte L1 complex light chain; Migration inhibitory factor-related protein 8; MRP-8; Pro-inflammatory S100 cytokine; S100 calcium-binding protein A8; Caga; Mrp8	Rat	E. coli
	S100A8 protein functions as a danger signal in inflammation, activating innate immune cells by binding to receptors like Toll-like receptor 4 (TLR4) and receptor for advanced glycation endproducts (AGER). This triggers signaling pathways that enhance the pro-inflammatory response. S100A8 Protein, Rat (His) is the recombinant rat-derived S100A8 protein, expressed by E. coli , with C-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80235

	*Myosin Light* Chain 2 Antibody (YA278)**	WB, IHC-P, IP	Human, Mouse, Rat
	Myosin Light Chain 2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 19 kDa, targeting to Myosin Light Chain 2. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human, Mouse, Rat.

HY-P82964

	*Myosin Light* Chain 2 Antibody (YA2709)** Myosin regulatory light chain 2; ventricular/cardiac muscle isoform; MLC-2; MLC-2v	WB, IHC-P, IP	Human, Mouse, Rat
	Myosin Light Chain 2 Antibody (YA2709) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2709), targeting MYL2, with a predicted molecular weight of 19 kDa (observed band size: 19 kDa). Myosin Light Chain 2 Antibody (YA2709) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.

HY-P82348

	MYL9 Antibody (YA2093) MLC2; CMH10; MLC-2C; Myosin RLC; Myosin regulatory light chain 2; smooth muscle isoform; Myosin regulatory light chain 9; Myosin regulatory light chain MRLC1	WB, IHC-P, IP	Human, Mouse, Rat
	MYL9 Antibody (YA2093) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2093), targeting MYL9, with a predicted molecular weight of 20 kDa (observed band size: 20 kDa). MYL9 Antibody (YA2093) can be used for WB, IHC-P, IP experiment in human, mouse, rat background.

HY-P80236

	*Myosin light* chain kinase/MLCK Antibody (YA277)**	WB, ICC/IF, IHC-P, FC	Human, Mouse, Rat
	Myosin light chain kinase/MLCK Antibody (YA277) is a non-conjugated and Rabbit origined monoclonal antibody about 211 kDa, targeting to Myosin light chain kinase. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

HY-P85290

	MYL3 Antibody (YA4982) MYL3; Myosin light chain 3; Cardiac myosin light chain 1; CMLC1; Myosin light chain 1; slow-twitch muscle B/ventricular isoform; MLC1SB; Ventricular/slow twitch myosin alkali light chain	WB, IHC-P, ICC/IF, ELISA	Human
	MYL3 Antibody (YA4982) is a mouse-derived and non-conjugated monoclonal antibody, targeting to MYL3. It can be applicated for WB, IHC-P, ICC/IF, ELISA assays, in the background of human.

HY-P86212

	MYL9 Antibody (YA5904) MYL9; MLC2; MRLC1; MYRL2; Myosin regulatory light polypeptide 9; 20 kDa myosin light chain; LC20; MLC-2C; Myosin RLC; Myosin regulatory light chain 2; smooth muscle isoform; Myosin regulatory light chain 9; Myosin regulatory light chain MRL	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	MYL9 Antibody (YA5904) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to MYL9. It can be applicated for WB, IHC-P, ICC/IF, IP, ELISA assays, in the background of human, mouse, rat.

HY-P83781

	Mouse anti Human Kappa Light Chain Mouse-anti-Human-Kappa-light-chain-Antibody; Mouse Anti-Human Ig kappa chain; Mouse Anti Human Ig kappa chain	ELISA	Human
	Mouse anti Human Kappa Light Chain is a mouse-derived and non-conjugated IgG1 recombinant monoclonal antibody, targeting to κ-Light Chain. It can be applicated for ELISA assays, in the background of human.

HY-P86082

	Phospho-MYL9(Thr18/Ser19) Antibody (YA5774) MYL9; MLC2; MRLC1; MYRL2; Myosin regulatory light polypeptide 9; 20 kDa myosin light chain; LC20; MLC-2C; Myosin RLC; Myosin regulatory light chain 2; smooth muscle isoform; Myosin regulatory light chain 9; Myosin regulatory light chain MRL	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Phospho-MYL9(Thr18/Ser19) Antibody (YA5774) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to phosphorylated MYL9 (Thr18/Ser19). It can be applicated for WB, IHC-P, ICC/IF, IP, ELISA assays, in the background of human, mouse, rat.

HY-P86430

	*Myosin Light* Chain 2 Antibody (YA6122)** Myosin regulatory light chain 2, ventricular/cardiac muscle isoform (MLC-2) (MLC-2v)	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Myosin Light Chain 2 Antibody (YA6122) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Myosin Light Chain 2. It can be applicated for WB, IHC-P, ICC/IF, IP, ELISA assays, in the background of human, mouse, rat.

HY-P85289

	*Myosin Light* Chain 2 Antibody (YA4981)** MYL2; Myosin regulatory light chain 2; ventricular/cardiac muscle isoform; MLC-2; MLC-2v	WB, ELISA	Human
	Myosin Light Chain 2 Antibody (YA4981) is a mouse-derived and non-conjugated monoclonal antibody, targeting to MYL2. It can be applicated for WB, ELISA assays, in the background of human.

HY-P85688

	*Rabbit IgG (Light* Chain Specific) Antibody (YA5380)**	WB	Rabbit
	Rabbit IgG (Light Chain Specific) Antibody (YA5380) is a mouse-derived and non-conjugated monoclonal antibody, targeting to IgG (Light Chain Specific). It can be applicated for WB assays, in the background of rabbit.

HY-P83388

	*Myosin light* chain kinase/MLCK Antibody (YA3133)** KMLS; KRP; MLCK; MYLK; myosin light chain kinase; smooth muscle and non-muscle isozymes; myosin light polypeptide kinase; telokin	WB, IHC-P, ICC/IF, FC	Human, Mouse, Rat
	Myosin light chain kinase/MLCK Antibody (YA3133) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3133), targeting MYLK, with a predicted molecular weight of 211 kDa. Myosin light chain kinase/MLCK Antibody (YA3133) can be used for WB, IHC-P, ICC/IF, FC experiment in human, mouse, rat background.

HY-P81275

	*Ferritin Light* Chain Antibody (YA971)** Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; LFTD; MGC71996; NBIA 3; NBIA3.	ELISA	Human
	Ferritin Light Chain Antibody (YA971) is a mouse-derived non-conjugated IgG2b antibody (Clone NO.: YA971), targeting Ferritin Light Chain. Ferritin Light Chain Antibody (YA971) can be used for ELISA experiment in human background.

HY-P81275A

	*Ferritin Light* Chain Antibody (YA972)** Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; LFTD; MGC71996; NBIA 3; NBIA3.	ELISA	Human
	Ferritin Light Chain Antibody (YA972) is a mouse-derived non-conjugated IgG2a antibody (Clone NO.: YA972), targeting Ferritin Light Chain. Ferritin Light Chain Antibody (YA972) can be used for ELISA experiment in human background.

HY-P85608

	*Ferritin Light* Chain Antibody (YA5300)** Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; LFTD; MGC71996; NBIA 3; NBIA3.	ELISA	Human
	Ferritin Light Chain Antibody (YA5300) is a mouse-derived and non-conjugated monoclonal antibody, targeting to Ferritin Light Chain. It can be applicated for ELISA assays, in the background of human.

HY-P87027

	Phospho-MYL9 (T18 + S19) Antibody (YA6720) 20 kDa myosin light chain antibody; Human 20kDa myosin light chain (MLC2) mRNA complete cds antibody; LC20 antibody; MGC3505 antibody; MLC 2 antibody; MLC-2C antibody; MLC2 antibody; MLY 9 antibody; MRLC1 antibody; MYL9 antibody; 20 kDa myosin light chain antibody; Human 20kDa myosin light chain (MLC2) mRNA complete cds antibody; LC20 antibody; MGC3505 antibody; MLC 2 antibody; MLC-2C antibody; MLC2 antibody; MLY 9 antibody; MRLC1 antibody; MYL9 antibody; MYL9_HUMAN antibody; Myosin light chain 9 regulatory antibody; Myosin light polypeptide 9 regulatory antibody; myosin regulatory light chain 1 antibody; Myosin regulatory light chain 2 antibody; Myosin regulatory light chain 2 smooth muscle isoform antibody; Myosin regulatory light chain 9 antibody; Myosin regulatory light chain MRLC1 antibody; Myosin regulatory light polypeptide 9 antibody; Myosin RLC antibody; Myosin vascular smooth muscle light chain 2 antibody; MYRL2 antibody; OTTHUMP00000030857 antibody; smooth muscle isoform antibody	WB	Mouse, Rat

HY-P84052

	*Myosin Light* Chain 2 Antibody (YA3749)** MLC2; CMH10; DKFZp779C0562	WB, ELISA	Human
	Myosin Light Chain 2 Antibody (YA3749) is a mouse-derived and non-conjugated IgG1 antibody, targeting to MYL2. It can be applicated for WB, ELISA assays, in the background of human.

HY-P85764

	LC3A Antibody (YA5456) Microtubule-associated proteins 1A/1B light chain 3A; Autophagy-related protein LC3 A; Autophagy-related ubiquitin-like modifier LC3 A; MAP1 light chain 3-like protein 1; MAP1A/MAP1B light chain 3 A; MAP1A/MAP1B LC3 A; Microtubule-associated protein 1 light chain 3 alpha;	WB, ICC/IF, IHC-P	Human, Rat, Mouse
	LC3A Antibody (YA5456) is a mouse-derived and non-conjugated monoclonal antibody, targeting to LC3A. It can be applicated for WB, ICC/IF, IHC-P assays, in the background of human, rat, mouse.

HY-P86550

	LC3A Antibody (YA6242) Microtubule-associated proteins 1A/1B light chain 3A; Autophagy-related protein LC3 A; Autophagy-related ubiquitin-like modifier LC3 A; MAP1 light chain 3-like protein 1; MAP1A/MAP1B light chain 3 A; MAP1A/MAP1B LC3 A; Microtubule-associated protein 1 light chain 3 alpha;	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	LC3A Antibody (YA6242) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to LC3A. It can be applicated for WB, IHC-P, ICC/IF, IP, ELISA assays, in the background of human, mouse, rat.

HY-P82251

	*Human kappa Light* Chain Antibody (YA1996)** HCAK1; Ig kappa chain C region; IGKC; IMMUNOGLOBULIN InV; Km	WB, IHC-P, ICC/IF	Human
	Human kappa Light Chain Antibody (YA1996) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1996), targeting Human kappa Light Chain, with a predicted molecular weight of 12 kDa (observed band size: 26 kDa). Human kappa Light Chain Antibody (YA1996) can be used for WB, IHC-P, ICC/IF experiment in human background.

HY-P86949

	*Lambda Light* Chain Antibody (YA6642)** Constant region of lambda light chains antibody; Ig lambda chain C regions antibody; IGLC antibody; Immunoglobulin lambda constant 1 antibody; Mcg marker antibody	WB, ICC/IF, IHC-P, FC	Human

HY-P86933

	KLC3 Antibody (YA6626) Kinesin light chain 2 antibody; Kinesin light chain 3 antibody; KLC2 antibody; KLC2 like antibody; KLC2-like antibody; KLC2L antibody; KLC3 antibody; KLC3_HUMAN antibody; KLCt antibody; KNS2B antibody	WB, ICC/IF, FC	Human, Mouse, Rat

HY-P86836

	Cathepsin H Antibody (YA6529) Pro-cathepsin H Cathepsin H mini chain Cathepsin H EC:3.4.22.16 Cathepsin H heavy chain Cathepsin H light chain CTSH CPSB	WB, ICC/IF	Human

HY-P83518

	*Dynein Light* Chain Tctex Type 1 Antibody (YA3263)** CW-1; TCTEL1; tctex-1	WB, IHC-F, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	Dynein Light Chain Tctex Type 1 Antibody (YA3263) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3263), targeting Dynein Light Chain Tctex Type 1, with a predicted molecular weight of 12 kDa (observed band size: 12 kDa). Dynein Light Chain Tctex Type 1 Antibody (YA3263) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human, mouse, rat background.

HY-P81608

	Factor IX Antibody (YA1353) Coagulation factor IX; Christmas factor; Plasma thromboplastin component; PTC [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain]	WB	Human
	Factor IX Antibody (YA1353) is a non-conjugated IgG antibody, targeting Factor IX, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Factor IX Antibody (YA1353) can be used for WB experiment in human background.

HY-P86911

	*Human Kappa light* chain Antibody (YA6604)** Immunoglobulin kappa variable 1D-16 Ig kappa chain V-I region HK146 Ig kappa chain V-I region HK189 Immunoglobulin kappa constant Ig kappa chain C regionCurated Ig kappa chain C region AG Ig kappa chain C region CUM Ig kappa chain C region EU Ig kappa chain C region OU Ig kappa chain C region ROY Immunoglobulin kappa variable 1D-16 Ig kappa chain V-I region HK146 Ig kappa chain V-I region HK189 Immunoglobulin kappa constant Ig kappa chain C regionCurated Ig kappa chain C region AG Ig kappa chain C region CUM Ig kappa chain C region EU Ig kappa chain C region OU Ig kappa chain C region ROY Ig kappa chain C region TI	WB, IHC-P	Human

HY-P85362

	S100A10/P11 Antibody (YA5054) S100A10; ANX2LG; CAL1L; CLP11; Protein S100-A10; Calpactin I light chain; Calpactin-1 light chain; Cellular ligand of annexin II; S100 calcium-binding protein A10; p10 protein; p11	WB, IHC-P, ICC/IF, ELISA	Human
	S100A10/P11 Antibody (YA5054) is a mouse-derived and non-conjugated monoclonal antibody, targeting to S-100A10. It can be applicated for WB, IHC-P, ICC/IF, ELISA assays, in the background of human.

HY-P84598

	*Myosin light* chain kinase/MLCK Antibody (YA4295)** KRP; AAT7; MLCK; MLCK1; MMIHS; MYLK1; smMLCK; MLCK108; MLCK210; MSTP083	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse
	Myosin light chain kinase/MLCK Antibody (YA4295) is a mouse-derived and non-conjugated IgG1 antibody, targeting to MYLK. It can be applicated for WB, IHC-P, ICC/IF, FC, ELISA assays, in the background of human, mouse.

HY-P83618

	Plasma Kallikrein Antibody (YA3363) Fletcher factor; kallikrein B plasma; Kallikrein B1; Kininogenin; KLK3; KLKB1; PKK; PKKD; Plasma kallikrein light chain; PPK; Prekallikrein	WB, IHC-P, IP	Human, Rat
	Plasma Kallikrein Antibody (YA3363) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3363), targeting Plasma Kallikrein, with a predicted molecular weight of 71 kDa (observed band size: 80 kDa). Plasma Kallikrein Antibody (YA3363) can be used for WB, IHC-P, IP experiment in human, rat background.

HY-P81448

	SLC7A5/LAT1 Antibody (YA1193) SLC7A5; CD98LC, LAT1; MPE16; Large neutral amino acids transporter small subunit 1; 4F2 light chain (4F2 LC; 4F2LC); CD98 light chain; Integral membrane protein E16; Solute carrier family 7 member 5	IHC-P	Human
	SLC7A5/LAT1 Antibody (YA1193) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1193), targeting SLC7A5/LAT1. SLC7A5/LAT1 Antibody (YA1193) can be used for IHC-P experiment in human background.

HY-P81662

	GCLM Antibody (YA1407) GCLM; GLCLR; Glutamate--cysteine ligase regulatory subunit; GCS light chain; Gamma-ECS regulatory subunit; Gamma-glutamylcysteine synthetase regulatory subunit; Glutamate--cysteine ligase modifier subunit	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
	GCLM Antibody (YA1407) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1407), targeting GCLM, with a predicted molecular weight of 31 kDa (observed band size: 31 kDa). GCLM Antibody (YA1407) can be used for WB, IHC-P, ICC/IF, IP, FC experiment in human, mouse, rat background.

HY-P83017

	Dynactin Subunit 3 Antibody (YA2762) DCNT22; DCTN22; Dctn3; dynactin 3 (p22); dynactin light chain; Dynactin subunit 3; p22	WB, IHC-P, ICC/IF	Human, Mouse, Rat
	Dynactin Subunit 3 Antibody (YA2762) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2762), targeting Dynactin Subunit 3, with a predicted molecular weight of 21 kDa (observed band size: 21 kDa). Dynactin Subunit 3 Antibody (YA2762) can be used for WB, IHC-P, ICC/IF experiment in human, mouse, rat background.

HY-P86557

	GCLM Antibody (YA6249) GCLM; GLCLR; Glutamate--cysteine ligase regulatory subunit; GCS light chain; Gamma-ECS regulatory subunit; Gamma-glutamylcysteine synthetase regulatory subunit; Glutamate--cysteine ligase modifier subunit	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	GCLM Antibody (YA6249) is a rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to GCLM. It can be applicated for WB, IHC-P, ICC/IF, IP, ELISA assays, in the background of human, mouse, rat.

HY-P85882

	MPO Antibody (YA5574) 84 kDa myeloperoxidase antibody; 89 kDa myeloperoxidase antibody; EC1.11.2.2 antibody; fj80f04 antibody; MPO antibody; mpx antibody; myeloid-specific peroxidase antibody; Myeloperoxidase antibody; Myeloperoxidase heavy chain antibody; Myeloperoxidase light chain antibody; PERM_HUMAN antibody; wu:fj80f04 antibody	IHC-P, WB, ICC/IF, ELISA	Human, Mouse, Rat
	MPO Antibody (YA5574) is a mouse-derived and non-conjugated IgG monoclonal antibody, targeting to MPO. It can be applicated for IHC-P, WB, ICC/IF, ELISA assays, in the background of human, mouse, rat.

HY-P85530

	IKK beta Antibody (YA5222) I kappa B kinase 2; I kappa B kinase beta; I-kappa-B kinase 2; I-kappa-B-kinase beta; IkBKB; IKK 2; IKK B; IKK beta; IKK-B; IKK-beta; IKK2; IKKB; IKKB_HUMAN; IMD15; Inhibitor of kappa light chain gene enhancer in B cells; Inhibitor of kappa light polypeptide gene enhancer in B cells; Inhibitor of kappa light polypeptide gene enhancer in B cells kinase beta; Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase beta; Inhibitor of nuclear factor kappa B kinase beta subunit; Inhibitor of nuclear factor kappa B kinase subunit beta; Inhibitor of nuclear factor kappa-B kinase subunit beta; MGC131801; NFKBIKB; Nuclear factor NF kappa B inhibitor kinase beta; Nuclear factor NF-kappa-B inhibitor kinase beta; Nuclear factor of kappa light chain gene enhancer in B cells inhibitor.	WB	Human, Rat
	IKK beta Antibody (YA5222) is a mouse-derived and non-conjugated monoclonal antibody, targeting to IKKβ. It can be applicated for WB assays, in the background of human, rat.

HY-P86837

	Cathepsin L/V/K/H Antibody (YA6530) Cathepsin L antibody; cathepsin L 1 b antibody; Cathepsin L1 antibody; Cathepsin L1 light chain antibody; CathepsinL antibody; CATL antibody; CATL1_HUMAN antibody; cb15 antibody; CTSL antibody; Cathepsin L antibody; cathepsin L 1 b antibody; Cathepsin L1 antibody; Cathepsin L1 light chain antibody; CathepsinL antibody; CATL antibody; CATL1_HUMAN antibody; cb15 antibody; CTSL antibody; CTSL1 antibody; ctsl1b antibody; FLJ31037 antibody; hgg1 antibody; Major excreted protein antibody; MEP antibody; MGC123162 antibody; wu:fb30g09 antibody;	WB, IF-Tissue, IHC-P	Human, Mouse, Rat

HY-P86838

	Cathepsin L Antibody (YA6531) Cathepsin L antibody; cathepsin L, 1 b antibody; Cathepsin L1 antibody; Cathepsin L1 light chain antibody; CathepsinL antibody; CATL antibody; CATL1_HUMAN antibody; cb15 antibody; CTSL antibody; CTSL1 antibody; Cathepsin L antibody; cathepsin L, 1 b antibody; Cathepsin L1 antibody; Cathepsin L1 light chain antibody; CathepsinL antibody; CATL antibody; CATL1_HUMAN antibody; cb15 antibody; CTSL antibody; CTSL1 antibody; ctsl1b antibody; FLJ31037 antibody; hgg1 antibody; Major excreted protein antibody; MEP antibody; MGC123162 antibody; wu:fb30g09 antibody	WB, IHC-P, FC	Human, Mouse, Rat, Monkey

HY-P81425

	S100 A8 Antibody (YA1170) Calgranulin-A antibody; Calprotectin L1L subunit antibody; CFAG antibody; Cystic fibrosis antigen antibody; Leukocyte L1 complex light chain antibody; Migration inhibitory factor-related protein 8 antibody; MRP-8 antibody; N-terminally processed antibody; p8 antibody; Protein S100-A8 antibody; S100 calcium-binding protein A8 antibody; S100A8 antibody; S10A8_HUMAN antibody; Urinary stone protein band A antibody	WB, IHC-P, ICC/IF, IP, FC, IF-Tissue	Human
	S100 A8 Antibody (YA1170) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1170), targeting S100A8. S100 A8 Antibody (YA1170) can be used for WB, IHC-P, IF-Cell, FC, IF-Tissue, IP experiment in human background.

HY-P87026

	Phospho-IKB alpha (S36) Antibody (YA6719) I kappa B alpha antibody; I-kappa-B-alpha antibody; IkappaBalpha antibody; IkB-alpha antibody; IKBA antibody; IKBA_HUMAN antibody; IKBalpha antibody; MAD 3 antibody; MAD3 antibody; Major histocompatibility complex enhancer-binding protein MAD3 antibody; I kappa B alpha antibody; I-kappa-B-alpha antibody; IkappaBalpha antibody; IkB-alpha antibody; IKBA antibody; IKBA_HUMAN antibody; IKBalpha antibody; MAD 3 antibody; MAD3 antibody; Major histocompatibility complex enhancer-binding protein MAD3 antibody; NF kappa B inhibitor alpha antibody; NF-kappa-B inhibitor alpha antibody; NFKBI antibody; NFKBIA antibody; Nuclear factor of kappa light chain gene enhancer in B cells antibody; Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha antibody	WB	Human, Mouse, Rat

HY-P80244

	NF-KB p105/p50 Antibody (YA699) DKFZp686C01211 antibody; DNA binding factor KBF1 antibody; DNA binding factor KBF1 EBP1 antibody; DNA-binding factor KBF1 antibody; EBP 1 antibody; EBP-1 antibody; EBP1 antibody; KBF1 antibody; MGC54151 antibody; NF kappa B antibody; NF kappaB antibody; NF kappabeta antibody; NF kB1 antibody; NFkappaB antibody; NFKB 1 antibody; NFKB p105 antibody; NFKB p50 antibody; Nfkb1 antibody; NFKB1_HUMAN antibody; Nuclear factor kappa B DNA binding subunit antibody; Nuclear factor kappa-B, subunit 1 antibody; Nuclear factor NF kappa B p105 subunit antibody; Nuclear factor NF kappa B p50 subunit antibody; Nuclear factor NF-kappa-B p50 subunit antibody; Nuclear factor of kappa light chain gene enhancer in B cells 1 antibody; Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 antibody; Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 antibody; p105 antibody; p50 antibody; p84/NF-kappa-B1 p98 antibody; Transcription factor NFKB1 antibody	WB, ICC/IF, IHC-P	Human, Mouse
	NF-κB p105/p50 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to NF-κB p105/p50. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

HY-P86806

	CD41 Antibody (YA6499) antigen CD41 antibody; BDPLT16 antibody; BDPLT2 antibody; CD41 antibody; CD41B antibody; form 2 antibody; GP2B antibody; GPalpha IIb antibody; GPIIb antibody; GT antibody; antigen CD41 antibody; BDPLT16 antibody; BDPLT2 antibody; CD41 antibody; CD41B antibody; form 2 antibody; GP2B antibody; GPalpha IIb antibody; GPIIb antibody; GT antibody; GTA antibody; HPA3 antibody; Integrin alpha 2b antibody; Integrin alpha IIb antibody; Integrin alpha-IIb light chain antibody; Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) antibody; ITA2B_HUMAN antibody; Itga2b antibody; ITGAB antibody; platelet fibrinogen receptor, alpha subunit antibody; platelet glycoprotein IIb of IIb/IIIa complex antibody; Platelet membrane glycoprotein IIb antibody; platelet specific antigen BAK antibody; PPP1R93 antibody	IHC-P, FC, ICC/IF	Mouse

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

light chain

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

MCE Kits

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Antibodies

Natural
Products